Researchers from Canada reviewed the results of 26 trials to determine which of the weight loss jabs are the most effective ...

Intuitively, it would seem that GLP-1 use for obesity would reduce overall medical costs despite the increase in drug ...

On the surface, the formula for weight loss seems simple: eat less and move more. But giving that advice to someone with ...

MBX Biosciences Inc. (NASDAQ:MBX) revealed results from its Phase 1 single ascending dose and multiple ascending dose trial ...

Kwame Raoul’s office sent cease and desist letters to five unnamed medical spas in the Chicago area that were allegedly ...

The U.S. Food and Drug Administration has approved the first generic version of Victoza (liraglutide injection), ...

People with diabetes who were taking GLP-1 receptor agonist drugs such as tirzepatide and semaglutide had significantly lower ...

Zepbound is a glucagon-like peptide 1 drug that reduces appetite and food intake. The drug's active ingredient, tirzepatide, is marketed as Zepbound for weight loss and Mounjaro as a diabetes ...

Tesla chief Elon Musk dubbed himself “Ozempic Santa” in an X post on Christmas Day, marking the tech billionaire’s latest ...

The branded drugs, Zepbound and Mounjaro ... elected officials have raised concerns about the prices of brand-name glucagon-like peptide 1, or GLP-1. medications, and some insurance companies ...

Altimmune is entering both obesity and MASH markets with a powerful GLP-1/Glucagon dual-agonist drug called Pemvidutide, offering fat-specific weight loss and muscle preservation with a strong ...

Sarhan and his colleague Steven Klein at the Caron Treatment Centers in Florida and Pennsylvania have prescribed a range of so-called glucagon-like ... latest sign that drugs such as Mounjaro ...